Non-randomised Ebola trials-lessons for optimal outbreak research

Matthew Bates; Alimuddin Zumla; Giuseppe Ippolito; Simone Lanini; Philippe Brouqui; Antonino Di; Francesco Vairo; Francesco Maria Fusco; Sanjeev Krishna; Maria Rosaria Capobianchi; Henry Kyobe-Bosa; Vincenzo Puro; Roman Woelfel; Tatjana Avšič‐Županc; John P A Ioannidis; Gina Portella; Peter G. Kremsner; Osman Dar

Related publications

Letter2016

Non-randomised Ebola trials—lessons for optimal outbreak research

Giuseppe Ippolito, Simone Lanini, Philippe Brouqui, Antonino Di, Francesco Vairo, Francesco Maria Fusco, Sanjeev Krishna, Maria Rosaria Capobianchi, Henry Kyobe-Bosa, Vincenzo Puro, Roman Wölfel, Tatjana Avšič‐Županc, John P A Ioannidis, Gina Portella, Peter G. Kremsner, Osman Dar, Matthew Bates, Alimuddin Zumla

Article2015

Are adaptive randomised trials or non-randomised studies the best way to address the Ebola outbreak in west Africa?

Simone Lanini, Alimuddin Zumla, John P A Ioannidis, Antonino Di, Sanjeev Krishna, Lawrence O. Gostin, Enrico Girardi, Michel Pletschette, Gino Strada, Aldo Baritussio, Gina Portella, Giovanni Apolone, Silvio Cavuto, Roberto Satolli, Peter G. Kremsner, Francesco Vairo, Giuseppe Ippolito

Article2025

Research Communication: Effects of Screening Colonoscopy on Colorectal Cancer Mortality: Lessons From Comparative Analyses of Randomised Trials

Hermann Brenner, Д. В. Сергеев, Thomas Heisser, Michael Hoffmeister

Article2003

Randomised trials comparing chemotherapy regimens for advanced non-small cell lung cancer

John P A Ioannidis, Anastasia Polycarpou, Christos Ntais, Nicholas Pavlidis

Article2021

Treatment effects in randomised trials using routinely collected data for outcome assessment versus traditional trials: meta-research study

Kimberly A. Mc Cord, Hannah Ewald, Arnav Agarwal, Dominik Glinz, Soheila Aghlmandi, John P A Ioannidis, Lars G. Hemkens